Nutex Health (NASDAQ:NUTX) Stock Price Down 4.9% – Time to Sell?

Nutex Health Inc. (NASDAQ:NUTX)’s stock price dropped 4.9% during mid-day trading on Tuesday . The stock traded as low as $177.74 and last traded at $170.8370. Approximately 1,562 shares traded hands during trading, a decline of 99% from the average daily volume of 152,476 shares. The stock had previously closed at $179.55.

Wall Street Analysts Forecast Growth

NUTX has been the topic of several recent analyst reports. Wall Street Zen upgraded Nutex Health from a “buy” rating to a “strong-buy” rating in a report on Friday, November 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nutex Health in a research report on Monday. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Nutex Health currently has a consensus rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Stock Up 1.3%

The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The stock has a market cap of $1.20 billion, a PE ratio of 9.17 and a beta of -0.03. The business has a fifty day moving average of $135.16 and a 200-day moving average of $113.99.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings data on Tuesday, November 18th. The company reported $7.76 EPS for the quarter, topping the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The company had revenue of $243.99 million for the quarter, compared to the consensus estimate of $221.93 million.

Insider Activity at Nutex Health

In other news, CFO Jon Christian Bates acquired 750 shares of the firm’s stock in a transaction that occurred on Tuesday, November 25th. The stock was purchased at an average cost of $136.71 per share, for a total transaction of $102,532.50. Following the completion of the acquisition, the chief financial officer directly owned 5,638 shares of the company’s stock, valued at $770,770.98. The trade was a 15.34% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 36.92% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

Several large investors have recently modified their holdings of the business. PharVision Advisers LLC purchased a new stake in shares of Nutex Health in the 3rd quarter worth approximately $420,000. Quarry LP bought a new position in Nutex Health in the third quarter worth approximately $610,000. Millennium Management LLC lifted its holdings in Nutex Health by 191.1% during the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after buying an additional 61,308 shares during the period. Bank of America Corp DE boosted its position in Nutex Health by 197.3% during the 3rd quarter. Bank of America Corp DE now owns 11,045 shares of the company’s stock valued at $1,141,000 after acquiring an additional 7,330 shares in the last quarter. Finally, Topline Capital Management LLC boosted its position in Nutex Health by 80.0% during the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock valued at $57,505,000 after acquiring an additional 247,436 shares in the last quarter. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.